The haematological cancers lymphoma, leukaemia and myeloma represent 8% of all cancers and collectively are the fifth commonest cancer. Cure rates are high for some, whilst for those that are incurable durations of remission have improved. Following completion of chemotherapy the focus of care shifts to the management of the consequences of chemotherapy with the deployment of survivorship services. Multiple survivorship models exist with little evidence to demonstrate superiority of one approach versus another, with almost no evidence for haematological cancers.
In this project, you will develop a nurse led service, informed by patient needs, and undertake a randomised control trial to compare the nurse-led and consultant led follow-up. In this study of 60 patients, the aim is to understand patient and healthcare professional views, and explore the feasibility of conducting a definitive trial.
This is a full time PhD in Medical Sciences
For informal inquiries, please contact Dr. David Allsup, Senior Lecturer in Haematology ([email protected]
) or Maureen Twiddy, Senior Lecturer in Mixed Methods Research [email protected]
Location and Research Culture
Hull York Medical School’s unique partnership brings together the expertise of both the Universities of Hull and York and offers a thriving environment in which to conduct world-leading research. Strong partnerships with NHS Trusts and community health organisations offer a wide clinical base within which to study those conditions which most affect our communities – improving their health while developing research work that can be applied nationally and globally.
The School’s academic and clinical researchers at have a strong reputation for their work, 85% of which is classed as ‘world-leading’ or ‘internationally excellent’ (REF 2014). Their research is advancing improvements in healthcare – treatment, diagnosis and care – improving the health of people locally and impacting national and international health agendas. http://www.hyms.ac.uk
The student will join a dynamic research team and thriving community of graduate students from the UK and overseas in the Centre for Atherothrombosis and Metabolic Disease at the University of Hull. Many students also study in our laboratories at local hospitals across the city. This gives our students unparalleled access to the facilities, academic and clinical expertise to thrive in their research.
Dr. David Allsup, Senior Lecturer in Haematology and Honorary Consultant, Centre for Atherothrombosis and Metabolic Disease.
Email: [email protected]
To be arranged upon acceptance of an offer.
In order to qualify for this position, you will require an undergraduate degree with at least a 2.1, or equivalent, in a relevant subject (Nursing, Psychology, Social Work, Sociology or a related discipline). English Language IELTS 6.5 with a minimum 6.0 in all components.
How to Apply
All applications MUST be submitted through the HYMS Postgraduate Centre via the online application system: https://www.york.ac.uk/study/postgraduate/courses/apply?course=DRPMEDSMED3&level=postgraduate
Please apply for a “PhD in Medical Sciences” at Hull York Medical School. Please quote HYMS with the scholarship title when applying. In order for the Panel to get a sense of your academic background, commitment and interest, you are required to complete the application form in full and provide a research proposal/outline of academic interest. Research proposals and personal statements may be used in selecting applicants for interview. If you have any queries on how to apply, please email [email protected]
Applicants who are shortlisted for interview will be sent details of the date, time and venue via email. If you are not invited for interview, it means that your application has not been successful. Please note that we do not offer feedback to applicants who are not invited to the interview.